Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 166

The DOI matches its Crossref record.

Clinical Breast and Pelvic Examination Requirements for Hormonal Contraception: Current Practice vs Evidence

Stewart, Felicia H., Harper, Cynthia C., Ellertson, Charlotte E., Grimes, David A., Sawaya, George F., Trussell, James · 2001 · JAMA

Abstract

Clinical breast and pelvic examinations are commonly accepted practices prior to provision of hormonal contraception. Such examinations, however, may reduce access to highly effective contraceptive methods, and may therefore increase women's overall health risks. These unnecessary requirements also involve ethical considerations and unwittingly reinforce the widely held but incorrect perception that hormonal contraceptive methods are dangerous. This article reviews and summarizes the relevant medical literature and policy statements from major organizations active in the field of contraception. Consensus developed during the last decade supports a change in practice: hormonal contraception can safely be provided based on careful review of medical history and blood pressure measurement. For most women, no further evaluation is necessary. Pelvic and breast examinations and screening for cervical neoplasia and sexually transmitted infection, while important in their own right, do not provide information necessary for identifying women who should avoid hormonal contraceptives or who need further evaluation before making a decision about their use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.285.17.2232

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 48

  1. Faculty of Family Planning and Reproductive Health Care, Royal College of Obstetricians and Gynaecologists, 2000, First prescription of combined oral contraception: recommendations for clinical practice., Br J Fam Plann, 26, 27
  2. Hannaford, 1996, Evidence-guided prescribing of combined oral contraceptives: consensus statement, March 1996., Contraception, 54, 125, 10.1016/S0010-7824(96)00167-9 · doi:10.1016/s0010-7824(96)00167-9
  3. International Planned Parenthood Federation, 1995, IMAP statement on steroidal oral contraception., IPPF Med Bull, 29, 1
  4. International Planned Parenthood Federation, 1999, IMAP statement on injectable contraception., IPPF Med Bull, 33, 1
  5. Not Available, 1993, Revised oral contraceptive labeling: FDA approves recommendation allowing delay of pelvic exam., Contracept Rep, 4, 4
  6. Armstrong, 1994, SMART START: an option for adolescents to delay the pelvic examination and blood work in family planning clinics., J Adolesc Health, 15, 389, 10.1016/1054-139X(94)90262-3 · doi:10.1016/1054-139x(94)90262-3
  7. Harper, 2001, Provision of hormonal contraceptives without a mandatory pelvic exam: the First Stop demonstration project., Fam Plann Perspect, 33, 13, 10.2307/2673737 · doi:10.2307/2673737
  8. Sawaya, 2001, Cervical neoplasia risk in women provided hormonal contraception without a Pap smear., Contraception, 63, 57, 10.1016/S0010-7824(01)00175-5 · doi:10.1016/s0010-7824(01)00175-5
  9. Finer, 1998, Does the timing of the first family planning visit still matter?, Fam Plann Perspect, 30, 10.2307/2991523 · DOI
  10. Zabin, 1996, Adolescents with negative pregnancy test results: an accessible at-risk group., JAMA, 275, 113, 10.1001/jama.1996.03530260027026 · DOI
  11. Larsen, 1995, Experiences of the first pelvic examination in a random samples of Danish teenagers., Acta Obstet Gynecol Scand, 74, 137, 10.3109/00016349509008923 · DOI
  12. Millstein, 1984, Sources of anxiety about pelvic examinations among adolescent females., J Adolesc Health Care, 5, 105, 10.1016/S0197-0070(84)80008-X · doi:10.1016/s0197-0070(84)80008-x
  13. Frye, 1994, Increasing the incidence of routine pelvic examinations: behavioral medicine's contribution., Women Health, 21, 33, 10.1300/J013v21n01_03 · doi:10.1300/j013v21n01_03
  14. Kaunitz, 1999, Oral contraceptive health benefits: perception versus reality., Contraception, 59, 29S, 10.1016/S0010-7824(98)00135-8 · DOI
  15. International Planned Parenthood Federation, 1995, IMAP statement on steroidal oral contraception., IPPF Med Bull, 29, 1
  16. Barton, 1999, Does this patient have breast cancer?, JAMA, 282, 1270, 10.1001/jama.282.13.1270 · DOI · Paper page
  17. Abma, 1997, Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth., Vital Health Stat. Series 23: Data from the National Survey of Family Growth, 19, 1
  18. Trussell, 1997, Medical care cost savings from adolescent contraceptive use., Fam Plann Perspect, 29, 10.2307/2953412 · DOI
  19. Chiaffarino, 1998, Oral contraceptive use and benign gynecologic conditions: a review., Contraception, 57, 11, 10.1016/S0010-7824(97)00201-1 · DOI
  20. Chiaffarino, 1999, Use of oral contraceptives and uterine fibroids: results from a case-control study., Br J Obstet Gynaecol, 106, 857, 10.1111/bjo.1999.106.issue-8 · doi:10.1111/bjo.1999.106.issue-8
  21. Darney, 1999, Condom practices of urban teens using Norplant contraceptive implants, oral contraceptives, and condoms for contraception., Am J Obstet Gynecol, 180, 929, 10.1016/S0002-9378(99)70664-2 · doi:10.1016/s0002-9378(99)70664-2
  22. Brinton, 1990, Oral contraceptive use and risk of invasive cervical cancer., Int J Epidemiol, 19, 4, 10.1093/ije/19.1.4 · DOI
  23. Brinton, 1991, Oral contraceptives and cervical neoplasia., Contraception, 43, 581, 10.1016/0010-7824(91)90005-Z · DOI
  24. Jones, 1990, Risk factors for in situ cervical cancer: results from a case-control study., Cancer Res, 50, 3657
  25. Kjaer, 1993, Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark: role of oral contraceptive use., Cancer Causes Control, 4, 513, 10.1007/BF00052426 · doi:10.1007/bf00052426
  26. Hildesheim, 1990, Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers., Int J Cancer, 45, 860, 10.1002/(ISSN)1097-0215 · DOI · Paper page
  27. Negrini, 1990, Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix., Cancer Res, 50, 4670
  28. Ursin, 1994, Oral contraceptive use and adenocarcinoma of cervix., Lancet, 344, 1390, 10.1016/S0140-6736(94)90567-3 · DOI
  29. Shafer, 1998, Annual pelvic examination in the sexually active adolescent female: what are we doing and why are we doing it?, J Adolesc Health, 23, 68, 10.1016/S1054-139X(98)00066-4 · doi:10.1016/s1054-139x(98)00066-4
  30. Schachter, 1996, Routine pelvic examinations in asymptomatic young women., N Engl J Med, 335, 1847, 10.1056/NEJM199612123352417 · doi:10.1056/nejm199612123352417
  31. Bombard, 1996, The genetics of ovarian cancer: an assessment of current screening protocols and recommendations for counseling families at risk., Clin Obstet Gynecol, 39, 860, 10.1097/00003081-199612000-00013 · doi:10.1097/00003081-199612000-00013
  32. Grover, 1995, Is there any value in bimanual pelvic examination as a screening test?, Med J Aust, 162, 408, 10.5694/mja2.1995.162.issue-8 · doi:10.5694/mja2.1995.162.issue-8
  33. Thompson, 1998, Ovarian cancer screening: a primary care guide., Lippincotts Primary Care Pract, 2, 244
  34. Brown, 1995, The Best Intentions: Unintended Pregnancy and the Well-Being of Children and Families
  35. American College of Obstetricians and Gynecologists, 1996, Guidelines for Women's Health Care
  36. American College of Obstetricians and Gynecologists, 1999, Oral Contraceptives for Adolescents: Benefits and Safety
  37. Society of Obstetricians and Gynaecologists of Canada, 1998, The Canadian Consensus Conference on Contraception., 20
  38. Not Available, 1999, Physicians' Desk Reference
  39. New York: Planned Parenthood Federation of America, 1996, Manual of Medical Standards and Guidelines
  40. New York: Planned Parenthood Federation of America, 1999, Manual of Medical Standards and Guidelines: Hormonal Contraceptive Use
  41. World Health Organization, 1996, Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria For Initiating and Continuing Use of Contraceptive Methods
  42. World Health Organization, 2000, Medical Eligibility Criteria For Initiating and Continuing Use of Contraceptive Methods
  43. World Health Organization and U.S. Agency for International Development, 1994, Recommendations for Updating Selected Practices in Contraceptive Use, Volume I.
  44. Ries, 1997, SEER Cancer Statistics Review, 1973-1994
  45. Not Available, 1996, US Preventive Services Task Force, Guide to Clinical Preventive Services
  46. Hatcher, 1998, Contraceptive Technology
  47. Perkins, 1996, Cancer incidence and mortality in California by race/ethnicity, 1988-1993
  48. American College of Obstetricians and Gynecologists, 1994, Technical Bulletin 198 on Hormonal Contraception

Cited by

See all 166

Metadata

Authors
Stewart, F. H., Harper, C. C., Ellertson, C. E., Grimes, D. A., Sawaya, G. F., & Trussell, J.
Venue
JAMA
Published
2001-05-02
Volume
285
Issue
17
Pages
2232
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2104735330
Cited by
166
References
0
FWCI
10.33
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Breast and Pelvic Examination Requirements for Hormonal Contraception: Current Practice vs Evidence. https://app.cochat.ai/papers/10.1001/jama.285.17.2232
The paper
Stewart, F. H., Harper, C. C., Ellertson, C. E., Grimes, D. A., Sawaya, G. F., & Trussell, J. (2001). Clinical Breast and Pelvic Examination Requirements for Hormonal Contraception: Current Practice vs Evidence. JAMA. https://doi.org/10.1001/jama.285.17.2232

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.